총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Checkpoint Therapeutics, Inc. (CKPT), 포함 28 건 매수 및 20 건 매도. 내부자 매수 총액은 $129K 내부자 매도 총액은 $32.76M.
최근 활동이 있는 주요 내부자에는 Rosenwald Lindsay A Md, Weiss Michael S, Herskowitz Neil. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — CKPT
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2025-05-30 |
Rosenwald Lindsay A Md |
Director |
공개매수 (매도) |
207,007 |
$4.10 |
$848.73K |
- |
| 2025-05-30 |
Weiss Michael S |
Director |
공개매수 (매도) |
187,007 |
$4.10 |
$766.73K |
- |
| 2025-05-30 |
Herskowitz Neil |
Director |
공개매수 (매도) |
147,007 |
$4.10 |
$602.73K |
- |
| 2025-05-30 |
Bechon Christian |
Director |
공개매수 (매도) |
141,718 |
$4.10 |
$581.04K |
- |
| 2025-05-30 |
Salzman Barry M |
Director |
공개매수 (매도) |
147,007 |
$4.10 |
$602.73K |
- |
| 2025-05-30 |
Oliviero James F Iii |
CEO, President and Director |
공개매수 (매도) |
3,759,929 |
$4.10 |
$15.42M |
- |
| 2025-05-30 |
Gray William Garrett |
Chief Financial Officer |
공개매수 (매도) |
1,446,322 |
$4.10 |
$5.93M |
- |
| 2025-05-30 |
Amit Sharma |
Director |
공개매수 (매도) |
94,246 |
$4.10 |
$386.41K |
- |
| 2025-05-30 |
Fortress Biotech, Inc. |
10 Percent Owner |
주식 반환 |
700,000 |
$4.10 |
$2.87M |
- |
| 2025-05-29 |
Rosenwald Lindsay A Md |
Director |
RSU 부여 |
50,000 |
$1.29 |
$64.5K |
207,007 |
| 2025-05-29 |
Weiss Michael S |
Director |
RSU 부여 |
50,000 |
$1.29 |
$64.5K |
187,007 |
| 2025-05-29 |
Fortress Biotech, Inc. |
10 Percent Owner |
정보 매도 |
100,000 |
$1.29 |
$129K |
6,122,249 |
| 2025-05-28 |
Rosenwald Lindsay A Md |
Director |
RSU 부여 |
12,195 |
- |
- |
157,007 |
| 2025-05-28 |
Weiss Michael S |
Director |
RSU 부여 |
12,195 |
- |
- |
137,007 |
| 2025-05-28 |
Herskowitz Neil |
Director |
RSU 부여 |
12,195 |
- |
- |
147,007 |
| 2025-05-28 |
Bechon Christian |
Director |
RSU 부여 |
12,195 |
- |
- |
141,718 |
| 2025-05-28 |
Salzman Barry M |
Director |
RSU 부여 |
12,195 |
- |
- |
147,007 |
| 2025-05-28 |
Amit Sharma |
Director |
RSU 부여 |
12,195 |
- |
- |
94,246 |
| 2025-04-02 |
Oliviero James F Iii |
CEO, President and Director |
정보 매도 |
15,090 |
$4.04 |
$60.96K |
3,759,929 |
| 2025-04-01 |
Gray William Garrett |
Chief Financial Officer |
정보 매도 |
12,322 |
$4.05 |
$49.9K |
1,446,322 |
| 2025-02-26 |
Fortress Biotech, Inc. |
10 Percent Owner |
RSU 부여 |
18,500 |
- |
- |
6,222,249 |
| 2025-02-10 |
Oliviero James F Iii |
CEO, President and Director |
정보 매도 |
10,331 |
$3.15 |
$32.54K |
3,775,019 |
| 2025-02-07 |
Oliviero James F Iii |
CEO, President and Director |
정보 매도 |
9,233 |
$3.41 |
$31.48K |
3,785,350 |
| 2025-02-06 |
Gray William Garrett |
Chief Financial Officer |
정보 매도 |
74,110 |
$3.67 |
$271.98K |
1,458,644 |
| 2025-01-30 |
Oliviero James F Iii |
CEO, President and Director |
RSU 부여 |
1,500,000 |
- |
- |
3,794,583 |
| 2025-01-30 |
Gray William Garrett |
Chief Financial Officer |
RSU 부여 |
500,000 |
- |
- |
1,532,754 |
| 2025-01-01 |
Fortress Biotech, Inc. |
10 Percent Owner |
RSU 부여 |
2,386,808 |
- |
- |
6,203,749 |
| 2024-12-31 |
Fortress Biotech, Inc. |
10 Percent Owner |
RSU 부여 |
81,407 |
- |
- |
3,816,941 |
| 2024-12-20 |
Oliviero James F Iii |
CEO, President and Director |
증여 (지급) |
900,000 |
- |
- |
2,294,583 |
| 2024-12-19 |
Oliviero James F Iii |
CEO, President and Director |
정보 매도 |
220,230 |
$3.38 |
$744.38K |
3,194,583 |
| 2024-12-18 |
Oliviero James F Iii |
CEO, President and Director |
정보 매도 |
602,167 |
$3.87 |
$2.33M |
3,414,813 |
| 2024-12-18 |
Gray William Garrett |
Chief Financial Officer |
정보 매도 |
268,432 |
$4.01 |
$1.08M |
1,032,754 |
| 2024-12-13 |
Rosenwald Lindsay A Md |
Director |
RSU 부여 |
12,638 |
- |
- |
144,812 |
| 2024-12-13 |
Weiss Michael S |
Director |
RSU 부여 |
12,638 |
- |
- |
124,812 |
| 2024-12-13 |
Herskowitz Neil |
Director |
RSU 부여 |
17,638 |
- |
- |
134,812 |
| 2024-12-13 |
Bechon Christian |
Director |
RSU 부여 |
14,994 |
- |
- |
129,523 |
| 2024-12-13 |
Salzman Barry M |
Director |
RSU 부여 |
17,638 |
- |
- |
134,812 |
| 2024-12-13 |
Oliviero James F Iii |
CEO, President and Director |
RSU 부여 |
2,077,700 |
- |
- |
4,016,980 |
| 2024-12-13 |
Gray William Garrett |
Chief Financial Officer |
RSU 부여 |
629,000 |
- |
- |
1,301,186 |
| 2024-09-27 |
Fortress Biotech, Inc. |
10 Percent Owner |
RSU 부여 |
146,341 |
- |
- |
3,735,534 |
| 2024-06-26 |
Oliviero James F Iii |
CEO, President and Director |
증여 (지급) |
37,890 |
- |
- |
1,939,280 |
| 2024-06-26 |
Gray William Garrett |
Chief Financial Officer |
정보 매도 |
13,038 |
$2.06 |
$26.86K |
672,186 |
| 2024-05-24 |
Oliviero James F Iii |
CEO, President and Director |
RSU 부여 |
1,660,000 |
- |
- |
2,001,780 |
| 2024-05-24 |
Gray William Garrett |
Chief Financial Officer |
RSU 부여 |
540,000 |
- |
- |
685,224 |
| 2024-05-16 |
Fortress Biotech, Inc. |
10 Percent Owner |
처분 |
700,000 |
- |
- |
- |
| 2024-05-14 |
Rosenwald Lindsay A Md |
Director |
RSU 부여 |
32,051 |
- |
- |
82,174 |
| 2024-05-14 |
Weiss Michael S |
Director |
RSU 부여 |
32,051 |
- |
- |
62,174 |
| 2024-05-14 |
Herskowitz Neil |
Director |
RSU 부여 |
32,051 |
- |
- |
67,174 |
| 2024-05-14 |
Bechon Christian |
Director |
RSU 부여 |
32,051 |
- |
- |
64,529 |
| 2024-05-14 |
Salzman Barry M |
Director |
RSU 부여 |
32,051 |
- |
- |
67,174 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료
